Global Oncothon 2026
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutated NSCLC After TKI Therapy
PRADO Trial: Neoadjuvant Ipilimumab Plus Nivolumab in Melanoma—5-Year Survival and Biomarker Analysis
Afreen Shariff Starts a New Position as Chair at ASCO for the ASPIRE Community of Practice
Community Oncology Alliance Shares 2025 End of Year Update on Advocacy and Practice Support
Breakthrough Innovations in Frontline TNBC Care - The Breast Friends Podcast
How the European Code Against Cancer Can Reduce Cancer Risk in Greece - ELLOK
In Memory of Kirsty Duncan: A Life Devoted to Science, Health, and Equity
The ELRIG Drug Discovery USA 2026, scheduled for June 16–17, 2026, is a free-to-attend event designed to bring together the global drug discovery community to discuss innovative research and emerging […]
